| ASCENDIS PHARMA ADR |
| USA |
| Gesundheit |
| US04351P1012 / A14M6X |
| A71 (Frankfurt) / ASND (NASDAQ) |
| FRA:A71, ETR:A71, A71:GR, NASDAQ:ASND |
| - |
| https://ascendispharma.co.. |
|
Ascendis Pharma A/S is a biopharmaceutical company..
>Volltext.. |
| 10518.98 Mio. EUR |
| 10820.29 Mio. EUR |
| 459.71 Mio. EUR |
| -220.46 Mio. EUR |
| -252.55 Mio. EUR |
| -4.27 EUR |
| 800.03 Mio. EUR |
| 498.72 Mio. EUR |
| -155.32 Mio. EUR |
| 0.53 |
| 55.77% |
| 44.58% |
| - |
| - |
| - |
| - |
| ASCENDIS |
| 28.10.25 |
|
||||
|